Cardiac Troponin I: A Valuable Biomarker Indicating the Cardiac Involvement in Fabry Disease-Reference-Cited by-同舟云学术

Cardiac Troponin I: A Valuable Biomarker Indicating the Cardiac Involvement in Fabry Disease

Published:2016-06-20 Issue:6 Volume:11 Page:e0157640
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Tanislav Christian,Guenduez Dursun,Liebetrau Christoph,Giese Anne Kathrin,Eichler Sabrina,Sieweke Nicole,Speth Maria,Bauer Timm,Hamm Christian,Rolfs Arndt

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference37 articles.

1. Angina in fabry disease reflects coronary small vessel disease;C Chimenti;Circ Heart Fail,2008

2. Anderson-Fabry disease: developments in diagnosis and treatment;AB Mehta;Int J Clin Pharmacol Ther,2009

3. Anderson-Fabry disease and the heart;C O'Mahony;Prog Cardiovasc Dis,2010

4. Terminal stage cardiac findings in patients with cardiac Fabry disease: an electrocardiographic, echocardiographic, and autopsy study;T Takenaka;J Cardiol,2008

5. Left ventricular hypertrophy in Fabry disease: a practical approach to diagnosis;Z Yousef;Eur Heart J,2013

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiac Troponin I-Responsive Nanocomposite Materials for Voltammetric Monitoring of Acute Myocardial Infarction;ACS Omega;2024-07-06

2. Biomarkers in anderson-Fabry disease: what should we use in the clinical practice?;Rare Disease and Orphan Drugs Journal;2024-04-25

3. SARS-CoV-2 Infection-Dependent Modulation in Vital Components of the Serum Profile of Severely SARS-CoV-2 Infected Patients;Infection and Drug Resistance;2024-04

4. Long‐term effectiveness of enzyme replacement therapy in Fabry disease with the p.Arg227Ter variant: Fabry disease in Ostrobothnia (FAST) study;American Journal of Medical Genetics Part A;2023-04-20

5. Disproportionate Elevations of Cardiac Troponin in Fabry Disease: A Case Series of False Positives due to Macrotroponin;Heart, Lung and Circulation;2022